<DOC>
	<DOC>NCT01876121</DOC>
	<brief_summary>This study is to assess the safety and efficacy of celecoxib on the pain relief from acute pain.</brief_summary>
	<brief_title>Celecoxib Japan Observational Study for the Patients With Acute Pain</brief_title>
	<detailed_description>Patients with traumatic pain, post-surgical and tooth extract pain will be included in this study. Patients will receive Celecoxib for 2 weeks and the efficacy on pain relief and the safety will be evaluated.</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients with traumatic pain, postsurgical pain and tooth extract pain Hyperreactive to sulfonamide Aspirin asthma patients Peptidic ulcer patients Serious liver disease patients Serious kidney disease patients Serious heart failure patients End of pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>NSAIDs</keyword>
	<keyword>Acute pain</keyword>
</DOC>